The present results also support previous reports documenting the downregulation of SELENBP1 CNVs and proteins in the blood of patients with schizophrenia (2, 3), suggesting that SELENBP1 and its associated biological correlates could potentially be peripheral diagnostic biomarkers of the negative symptoms. The gene discussed is SELENBP1; the disease is schizophrenia.